Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Extended duration vancomycin in recurrent Clostridium difficile infection: a systematic review.

Murphy MM, Patatanian E, Gales MA.

Ther Adv Infect Dis. 2018 Sep 12;5(6):111-119. doi: 10.1177/2049936118798276. eCollection 2018 Nov. Review.

2.

Effect of a multifaceted stewardship intervention on antibiotic prescribing and outcomes for acute bacterial skin and skin structure infections.

Roshdy D, Jaffa R, Pillinger KE, Guffey J, Rozario N, Davidson L, McCurdy L.

Ther Adv Infect Dis. 2018 Jul 10;5(6):103-109. doi: 10.1177/2049936118786424. eCollection 2018 Nov.

3.

Incidental peritoneal tuberculosis: surgeon's dilemma in endemic regions.

Krishnamurthy G, Rajendran J, Sharma V, Kumar H, Singh H.

Ther Adv Infect Dis. 2018 Jun 22;5(5):97-102. doi: 10.1177/2049936118783687. eCollection 2018 Sep.

4.

Fanconi syndrome due to tenofovir disoproxil fumarate reversed by switching to tenofovir alafenamide fumarate in an HIV-infected patient.

Mothobi NZ, Masters J, Marriott DJ.

Ther Adv Infect Dis. 2018 Jul 10;5(5):91-95. doi: 10.1177/2049936118785497. eCollection 2018 Sep.

5.

Optimal duration for continuation of statin therapy in bacteremic patients.

Pawar AM, LaPlante KL, Timbrook TT, Caffrey AR.

Ther Adv Infect Dis. 2018 May 17;5(5):83-90. doi: 10.1177/2049936118775926. eCollection 2018 Sep.

6.

Safety and tolerability of intrathecal liposomal amphotericin B (AmBisome) for cryptococcal meningitis: a retrospective study in HIV-infected patients.

Alvarez-Uria G, Midde M, Battula J, Pujari HNB.

Ther Adv Infect Dis. 2018 Jun 12;5(5):77-81. doi: 10.1177/2049936118782846. eCollection 2018 Sep.

7.

Mycobacterial chylous ascites: report of three cases and systematic review.

Mallick B, Mandavdhare HS, Aggarwal S, Singh H, Dutta U, Sharma V.

Ther Adv Infect Dis. 2018 Jul;5(4):69-75. doi: 10.1177/2049936118772754. Epub 2018 May 2. Review.

8.

A study of antibiotic prescription pattern in patients referred to tertiary care center in Northern India.

Kaur A, Bhagat R, Kaur N, Shafiq N, Gautam V, Malhotra S, Suri V, Bhalla A.

Ther Adv Infect Dis. 2018 Jul;5(4):63-68. doi: 10.1177/2049936118773216. Epub 2018 May 10.

9.

Clinical efficacy of 12-h metronidazole dosing regimens in patients with anaerobic or mixed anaerobic infections.

Soule AF, Green SB, Blanchette LM.

Ther Adv Infect Dis. 2018 May;5(3):57-62. doi: 10.1177/2049936118766462. Epub 2018 Apr 3.

10.

Corrigendum.

[No authors listed]

Ther Adv Infect Dis. 2017 Nov;4(6):193. doi: 10.1177/2049936117731199. Epub 2017 Oct 6.

11.

Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.

Calik Basaran N, Ascioglu S.

Ther Adv Infect Dis. 2017 Nov;4(6):171-191. doi: 10.1177/2049936117733394. Epub 2017 Oct 17. Review.

12.

Results of a local combination therapy antibiogram for Pseudomonas aeruginosa isolates: is double worth the trouble?

Song M, Dilworth TJ, Munson E, Davis J, Elshaboury RH.

Ther Adv Infect Dis. 2017 Nov;4(6):165-170. doi: 10.1177/2049936117725935. Epub 2017 Aug 23.

13.

Implementation of universal rapid human immunodeficiency virus screening on labor and delivery.

Crochet S, Huang CC, Fries M, Scott RK.

Ther Adv Infect Dis. 2018 Mar;5(2):47-54. doi: 10.1177/2049936117753012. Epub 2018 Jan 23.

14.

The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management.

Mokomane M, Kasvosve I, de Melo E, Pernica JM, Goldfarb DM.

Ther Adv Infect Dis. 2018 Jan;5(1):29-43. doi: 10.1177/2049936117744429. Epub 2017 Dec 7. Review.

15.

Examining the effectiveness of a cognitive intervention to improve cognitive function in a population of older adults living with HIV: a pilot study.

Frain JA, Chen L.

Ther Adv Infect Dis. 2018 Jan;5(1):19-28. doi: 10.1177/2049936117736456. Epub 2017 Oct 23.

16.

Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia.

Patolia S, Abate G, Patel N, Patolia S, Frey S.

Ther Adv Infect Dis. 2018 Jan;5(1):11-18. doi: 10.1177/2049936117727497. Epub 2017 Sep 12.

17.

Impact of an antifungal stewardship intervention on optimization of candidemia management.

Rac H, Wagner JL, King ST, Barber KE, Stover KR.

Ther Adv Infect Dis. 2018 Jan;5(1):3-10. doi: 10.1177/2049936117745267. Epub 2017 Dec 10.

18.

Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Pulido-Cejudo A, Guzmán-Gutierrez M, Jalife-Montaño A, Ortiz-Covarrubias A, Martínez-Ordaz JL, Noyola-Villalobos HF, Hurtado-López LM.

Ther Adv Infect Dis. 2017 Sep;4(5):143-161. doi: 10.1177/2049936117723228. Epub 2017 Aug 31. Review.

19.

Efficacy of raltegravir, etravirine and darunavir/ritonavir for treatment-experienced HIV patients from a non-urban clinic population in the United States.

Ebers AM, Alkabab Y, Wispelwey B, Dillingham R, Wang XQ, Schexnayder J, Heysell SK.

Ther Adv Infect Dis. 2017 Sep;4(5):135-142. doi: 10.1177/2049936117718101. Epub 2017 Jul 13.

20.

The role of nanotechnology in the treatment of viral infections.

Singh L, Kruger HG, Maguire GEM, Govender T, Parboosing R.

Ther Adv Infect Dis. 2017 Jul;4(4):105-131. doi: 10.1177/2049936117713593. Epub 2017 Jul 5. Review.

Supplemental Content

Loading ...
Support Center